862 research outputs found
A recently discovered clypeasteroid, Echinodiscus colchesterensis species novum, from the Alexandria Formation (Late Tertiary), South Africa
A recently discovered astriclypeid, Echinodiscus colchesterensis sp. nov. from the Late Tertiary of South Africa is described and classified as ancestral to the living E. bisperforatus on the basis of certain morphological characteristics and parameters. These include a smaller interlunule angle, different ambitus shape, breadth/ length ratio, and similar growth trends.CSIR post-graduate bursary; Institute for Coastal Research, University of Port Elizabet
High prevalence of TT virus in a rural community of South Africa
To the Editor: The development of new molecular techniques in recent years has resulted in the discovery of a number of novel viruses. Hepatitis C virus (HCV) was the first to be discovered in 1989 using immunoscreening methods 1 and since 1995 a further five new viruses have been identified using the same or modified technologies: GB virus-C/hepatitis G virus (GBV-C/HGV), 2,3 human herpesvirus 8 (HHV8),4 TT virus (TTV),5 SEN virus (SEN-V)6 and human metapneumovirus.7 In each case the prevalence of the virus in different communities, its association with disease and therefore its relevance in the hospital and blood transfusion settings needed to be established
Spinal cord stimulation for the management of pain: Recommendations for best clinical practice
Spinal cord stimulation (SCS) is an accepted method of pain control. SCS has been used for many years and is supported by a substantial evidence base. A multidisciplinary consensus group has been convened to create a guideline for the implementation and execution of an SCS programme for South Africa (SA). This article discusses the evidence and appropriate context of SCS delivery, and makes recommendations for patient selection and appropriate use. The consensus group has also described the possible complications following SCS. This guideline includes a literature review and a summary of controlled clinical trials of SCS. The group notes that, in SA, SCS is performed mainly for painful neuropathies, failed back surgery, and chronic regional pain syndrome. It was noted that SCS is used to treat other conditions such as angina pectoris and ischaemic conditions, which have therefore been included in this guideline. These recommendations give guidance to practitioners delivering this treatment, to those who may wish to refer patients for SCS, and to those who care for patients with stimulators in situ. The recommendations also provide a resource for organisations that fund SCS. This guideline has drawn on the guidelines recently published by the British Pain Society, and parts of which have beenreproduced with the society’s permission. These recommendations have been produced by a consensus group of relevant healthcare professionals. Opinion from outside the consensus group has been incorporated through consultation with representatives of all groups for whom these recommendations have relevance. The recommendations refer to the current body of evidence relating to SCS. The consensus group wishes to acknowledge and thank the task team of the British Pain Society for their help and input into this document
Supplementation of recombinant cellulases with LPMOs and CDHs improves consolidated bioprocessing of cellulose
The increased demand for energy has sparked a global search for renewable energy sources that could partly replace fossil fuel resources and help mitigate climate change. Cellulosic biomass is an ideal feedstock for renewable bioethanol production, but the process is not currently economically feasible due to the high cost of pretreatment and enzyme cocktails to release fermentable sugars. Lytic polysaccharide monooxygenases (LPMOs) and cellobiose dehydrogenases (CDHs) are auxiliary enzymes that can enhance cellulose hydrolysis. In this study, four LPMO and two CDH genes were subcloned and expressed in the Saccharomyces cerevisiae Y294 laboratory strain. SDS-PAGE analysis confirmed the extracellular production of the LPMOs and CDHs in the laboratory S. cerevisiae Y294 strain. A rudimentary cellulase cocktail (cellobiohydrolase 1 and 2, endoglucanase and β-glucosidase) was expressed in the commercial CelluX™ 4 strain and extracellular production of the individual cellulases was confirmed by SDS-PAGE analysis. In vitro cooperation of the CDHs and LPMOs with the rudimentary cellulases produced by strain CelluX™ 4[F4–1] was demonstrated on Whatman filter paper. The significant levels of soluble sugars released from this crystalline cellulose substrate indicated that these auxiliary enzymes could be important components of the CBP yeast cellulolytic system
A triangle of forces : language, religion and politics : inaugural lecture delivered at Rhodes University
Inaugural lecture delivered at Rhodes UniversityRhodes University Libraries (Digitisation
Die roeping en identiteit van die evangeliedienaar
Aanleiding tot die keuse van hierdie tema was 'n gesprek met 'n jong predikant wat slegs enkele maande tevore sy milit�re diensplig voltooi het. Hy het een en ander te vertel gehad omtrent sy ervaringe gedurende hierdie tyd. Dit is natuurlik moontlik om as dienspligkapelaan diens te doen sonder om werklik na aan die manskappe vir wie jy verantwoordelik is, te kom
On a new class of tests for the Pareto distribution using Fourier methods
We propose new classes of tests for the Pareto type I distribution using the
empirical characteristic function. These tests are and statistics based
on a characterisation of the Pareto distribution involving the distribution of
the sample minimum. In addition to deriving simple computational forms for the
proposed test statistics, we prove consistency against a wide range of fixed
alternatives. A Monte Carlo study is included in which the newly proposed tests
are shown to produce high powers. These powers include results relating to
fixed alternatives as well as local powers against mixture distributions. The
use of the proposed tests is illustrated using an observed data set
Expanding the epidemiological understanding of hepatitis C in South Africa: Perspectives from a patient cohort in a rural town
Background. The epidemiology of hepatitis C virus (HCV) in the general population of South Africa (SA) is incompletely understood. A high HCV prevalence in key populations is known, but data are limited in terms of a broader understanding of transmission risks in our general population.Objectives. To investigate a patient cohort with HCV infection clustering in a rural SA town, in order to identify possible HCV transmission risks, virological characteristics, phylogenetic data and treatment outcomes.Methods. A cluster of patients with positive HCV serology, previously identified from laboratory records, were contacted by a local district hospital and offered confirmatory testing for HCV viraemia where needed. Those with confirmed HCV RNA were invited to a local hospital visit, where relevant demographic information was recorded, clinical assessment performed and a confidential questionnaire administered. HCV population-based sequencing was performed on HCV NS3/4A, NS5A and NS5B using polymerase chain reaction-specific or M13 universal primers, and sequences were aligned using BioEdit 7.2.5. Phylogenetic trees were constructed. Clinical assessments included liver fibrosis determination with FibroScan (cut-off ≥12.5 kPa = F4). Patients were offered treatment, and sustained virological response (SVR) was confirmed by undetectable HCV RNA at least 12 weeks after the end of treatment.Results. Twenty-one patients, all from the same town, median (interquartile range (IQR)) age 64 (59 - 70) years, 57% female, were evaluated. Of these, 24% (n=5) were HIV co-infected, stable on antiretrovirals. The median (IQR) alanine aminotransferase level was 51 (31 - 89) U/L, with fibrosis distribution including 29% F1, 29% F2, 9% F3 and 33% F4 METAVIR fibrosis. Virologically, two genotypes were observed: 62% (n=13) genotype (GT) 1b and 38% (n=8) GT5a. No patient had ever used injecting drugs, 14% (n=3) had received blood products before 1992, and 9.5% (n=2) had undergone traditional healer-administered scarification. All (n=21) reported attendance at a single primary care clinic in the past, with most (n=20) recalling having received parenteral therapies at the clinic. Phylogenetic analysis of the HCV NS5A and NS5B regions confirmed GT1b and GT5a genotypes and formed two separate clusters within their respective genotypes, suggesting a common source for each genotype infection. Most patients received treatment with sofosbuvir/daclatasvir, 1 was treated with sofosbuvir/velpatasvir, and 1 was re-treated with sofosbuvir/velpatasvir/voxilaprevir. Per protocol SVR was 95%, with the non-SVR patient successfully re-treated.Conclusions. Data from a rural town cluster of patients suggest parenteral medical exposure as the probable common source of hepatitis C transmission risk. The cohort was of older age with a significant number having advanced fibrosis or cirrhosis, suggesting HCV acquisition in the distant past. Using a simplified care approach, treatment outcomes were very good
- …